Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons

Journal of Neurochemistry

Volumn 60, Issue 2, 1993, Pages 527-535

  Sulzer, David ^a,b   Maidment, Nigel T ^a,b   Rayport, Stephen ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3,4 Dihydroxyphenylacetic acid; Ammonium chloride; Amphetamine; Benztropine; Dopamine; Nomifensine

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMMONIUM CHLORIDE; AMPHETAMINE; BENZATROPINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; KYNURENIC ACID; MONENSIN; NOMIFENSINE; TETRODOTOXIN; TRIBUTYLAMINE; TRIETHANOLAMINE;

AMINE TRANSPORT; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL PH; CYTOPLASM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG MECHANISM; DRUG TRANSPORT; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE;

3,4-DIHYDROXYPHENYLACETIC ACID; AMINES; AMMONIUM CHLORIDE; ANIMAL; ANIMALS, NEWBORN; BENZTROPINE; BIOLOGICAL TRANSPORT; BUTYLAMINES; CELLS, CULTURED; DOPAMINE; ETHANOLAMINES; HYDROGEN-ION CONCENTRATION; KINETICS; MESENCEPHALON; MONENSIN; NEURONS; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027395913     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1993.tb03181.x     Document Type: Review

References (61)

1. 2+‐independent release of neurotransmitters
2. The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action
3. Thyrotropin induces the acidification of the secretory granules of parafollicular cells by increasing the chloride conductance of the granular membrane
4. Cell culture of neocortex and basal forebrain from postnatal rats
5. Experience, neurotransmitter plasticity, and behavior
6. Simultaneous evaluation by a double labeling method of drug‐induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum
7. Amphetamine‐induced dopamine release in the rat striatum: an in vivo microdialysis study
8. Ice: a new dosage form of an old drug
9. 3H‐dopamine release
10. Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum‐free conditions
11. Ammonia‐induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids
12. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model
13. Inability of methylphenidate or mazindol to prevent the lowering of 3,4‐dihydroxyphenylacetic acid in rat brain by amphetamine
14. Differences between the release of radiolabeled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine, and synthesis inhibition
15. 2+ dependence of the amphetamine, nomifensine, and LY 19–005 effect on in vivo dopamine transmission
16. 2 receptor in nonhuman primates
17. Accumulation of biological amines into chromaffin grarules: a model for hormone and neurotransmitter transport
18. 3H]‐dopamine from slices of the rabbit caudate
19. Cloning and expression of a cocaine‐sensitive rat dopamine transporter
20. Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs
21. Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus
22. Effect of monensin on synthesis, posttranslational processing, and secretion of dopamine β‐hydroxylase from PC12 pheochromocytoma cells
23. Amphetamine attenuates the stimulated release of dopamine in vivo
24. Role of intracellular pH in secretion from adrenal medulla chromaffin cells
25. 3H‐norepinephrine released from the adrenergic neuron
26. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine, and unlabeled dopamine
27. ++‐independent dopamine release from striatal slices: a possible role of reverse dopamine transport
28. Dissociation constants and lipophilicity of catecholamines and related compounds
29. Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast‐scan in vivo voltammetry
30. CNS stimulants: two distinct mechanisms of action for amphetamine‐like drugs
31. Application of a novel cation‐exchange reagent, Igepon T‐77 (N‐methyl oleoyl taurate), to microbore separations of alumina extracts of catecholamines from cerebrospinal fluid, plasma, urine, and brain tissue with amperometric detection
32. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances
33. Co‐release of acetylcholine and GABA by the starburst amacrine cells
34. Effects of d‐amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the absence of vesicular transmitter stores
35. Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis
36. Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpine
37. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture
38. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine
39. Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology
40. Effect of metaphit on dopaminergic neurotransmission in rat striatal slices: involvement of the dopamine transporter and voltage‐dependent sodium channel
41. Cocaine receptors on dopamine transporters are related to self‐administration of cocaine
42. 3H]WIN 35,065–2: a ligand for cocaine receptors in striatum
43. Catecholamine toxicity in cerebral cortex in dissociated cell culture
44. Hundred‐fold increase in neuronal vulnerability to glutamate toxicity in astrocyte‐poor cultures of rat cerebral cortex
45. The molecular mechanism of “ecstasy” [3,4‐methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA‐induced serotonin release
46. Effects of compounds which disrupt proton gradients on secretion of neurosecretory proteins from PC12 pheochromocytoma cells
47. Release of catecholamines from isolated medullary granules by sympathomimetic amines
48. Release of dopamine from coaggregate cultures of mesencephalic tegmentum and corpus striatum
49. Cloning and expression of a cocaine‐sensitive dopamine transporter complementary DNA
50. In vitro release of endogenous dopamine from the striatum of the weaver mutant mouse
51. Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data
52. Acidification and endosome‐like compartments in the presynaptic terminals of frog retinal photoreceptors
53. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action
54. Reverse action of the plasma membrane transporter mediates weak base‐induced dopamine release: implications for amphetamine action
55. Weak base model of amphetamine action
56. Amphetamine action examined in real‐time in the giant dopamine neuron of
57. Non‐vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake
58. Localization of drug reward mechanisms by intracranial injections
59. Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine
60. 3H‐amphetamine with rat brain synaptosomes. II. Active transport
61. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine‐releasing drugs: implications for the origin of extracellular DOPAC